Found: 12
Select item for more details and to access through your institution.
Population Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 2, p. 229, doi. 10.1002/jcph.1511
- By:
- Publication type:
- Article
971-P: Renal Impairment Has No Impact on the Clinical Pharmacokinetics of Tirzepatide.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-971-P
- By:
- Publication type:
- Article
LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1057, doi. 10.1007/s10637-021-01084-8
- By:
- Publication type:
- Article
Oral Olanzapine Disposition in Adolescents with Schizophrenia or Bipolar I Disorder.
- Published in:
- Pediatric Drugs, 2010, v. 12, n. 3, p. 201, doi. 10.2165/11532580-000000000-00000
- By:
- Publication type:
- Article
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01148-9
- By:
- Publication type:
- Article
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 7, p. 1057, doi. 10.1007/s40262-022-01140-3
- By:
- Publication type:
- Article
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 8, p. 1049, doi. 10.1007/s40262-021-01012-2
- By:
- Publication type:
- Article
Pharmacokinetics of Orally Administered Duloxetine in Children and Adolescents with Major Depressive Disorder.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 8, p. 731, doi. 10.1007/s40262-014-0149-y
- By:
- Publication type:
- Article
Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Orally Administered Duloxetine in Patients.
- Published in:
- Clinical Pharmacokinetics, 2009, v. 48, n. 3, p. 189, doi. 10.2165/00003088-200948030-00005
- By:
- Publication type:
- Article
In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine.
- Published in:
- Clinical Pharmacokinetics, 2008, v. 47, n. 3, p. 191, doi. 10.2165/00003088-200847030-00005
- By:
- Publication type:
- Article
Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women.
- Published in:
- Clinical Pharmacokinetics, 2008, v. 47, n. 2, p. 103, doi. 10.2165/00003088-200847020-00003
- By:
- Publication type:
- Article